| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.041 | 0.5 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.5 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |